RxDoctor Payments Data

James Stewart, MD

Internal Medicine · Sandy, UTNPI 1104022557

Payments from drug & device makers

$5,111in general payments, 2019–2025

Across 311 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$485
  • Takeda Pharmaceuticals U.S.A., Inc.$408
  • Fujifilm Healthcare Americas Corporation$344
  • Sanofi$214
  • Pfizer$212
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,62891%
  • Education$1393%
  • Gifts$1864%
  • Other$1583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,111 in reported general payments places this provider in the 85th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah

Medicare billing

Part B allowed, 2024
$27,100
Medicare patients
134
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole48$968
Dicyclomine Hcl29$577
Pantoprazole Sodium27$527
Ondansetron OdtOndansetron11$404
Lansoprazole15$324

Paid to pharmacies, not to this prescriber.

Other internal medicine in Sandy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →